Novartis Investigative Site

Majadahonda (Madrid) 28222

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic, Thrombocytopaenia

Studies at this site

• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) — Stopped early
• Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) — Completed